Balanced news tone
News Sentiment
ENP sentiment intelligence
Entropy Neurodynamics Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
88/100 classification confidence.
directly relevant articles
high-authority source matches
+9.4% over one week, +12.9% over four weeks, trend inactive, and materially above fair value.
Entropy Neurodynamics Granted Australian Patent for Psilocin Crystalline Forms
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Entropy Neurodynamics Granted Australian Patent for Psilocin Crystalline Forms
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 00:17
- Source
- marketscreener.com
Entropy Neurodynamics Secures Australian Patent for Psilocin Crystalline Forms
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 23:15
- Source
- Kalkine
Entropy Neurodynamics Limited (ASX: ENP) Share Price, ENP Stock News, ENP Share Price & Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 06:10
- Source
- Kalkine
Free cash flow per share of Entropy Neurodynamics Limited Warrant 2026-29.05.27 On Entropy Neurod – ASX:ENPO
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 01 Jul 2026 21:29
- Source
- TradingView
Entropy Neurodynamics Limited Warrant 2026-29.05.27 On Entropy Neurod
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 17:22
- Source
- TradingView
Entropy Neurodynamics Seeks ASX Quotation for Large Option Class
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 02:51
- Source
- TipRanks
ASX: ENP — Entropy Neurodynamics Rides Psychedelic Drug Approval Momentum Into the Spotlight
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 18 Jun 2026 07:00
- Source
- Kalkine
Biocurious: Entropy rides a supportive wave towards psychedelic drug approval
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 17 Jun 2026 07:00
- Source
- Stockhead
Entropy Neurodynamics (ASX:ENP) Shares Slip Despite DSMB Safety Clearance — What Do Investors Need to Know?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Kalkine
Entropy reports 75pc IBS clinical trial response
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- The Australian
Prenzler Group initiates coverage on Entropy Neurodynamics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Feb 2026 08:00
- Source
- The Australian
Entropy Neurodynamics Granted Australian Patent for TRP8803 to Treat Chronic Pain and Psychiatric Conditions
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Feb 2026 08:00
- Source
- smallcaps.com.au
Insights: Entropy Neurodynamics Ltd (ASX:ENP)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Nov 2025 05:50
- Source
- smallcaps.com.au
Entropy Neurodynamics Limited (ASX: ENP) - Announcements
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Nov 2025 14:54
- Source
- intelligentinvestor.com.au
ENP Stock Price and Chart — ASX:ENP
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Nov 2025 02:26
- Source
- TradingView
Entropy Neurodynamics Limited (ASX:ENP)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Nov 2025 17:24
- Source
- intelligentinvestor.com.au